Ilex Medical Cash Flow Conversion Efficiency

Latest as of June 2026: 0.070x

Ilex Medical cash flow conversion efficiency. Based on the latest financial reports, Ilex Medical (ILX) has a cash flow conversion efficiency ratio of 0.070x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA47.07 Million ≈ $126.19K USD) by net assets (ILA670.18 Million ≈ $1.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Ilex Medical (2008–2025)

Cash flow conversion efficiency of Ilex Medical from 2008 to 2025. This chart illustrates how Ilex Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Ilex Medical share price for real-time trading data and today's change.

Ilex Medical Cash Flow Conversion Ratio Explained

Ilex Medical cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Ilex Medical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ilex Medical ranked by their cash flow conversion efficiency. Also see Ilex Medical (ILX) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Bisalloy Steel Group Ltd AU:BIS	0.189x
Affinity Bancshares Inc NASDAQ:AFBI	0.034x
Prelude Therapeutics Inc NASDAQ:PRLD	-0.327x
CSG Holding Co Ltd SHE:200012	0.023x
TYM Corporation KO:002900	-0.078x
Batulicin Nusantara Maritim Tbk PT JK:BESS	0.019x
TerrAscend Corp F:TED	0.081x
D-Box Technologies Inc. TO:DBO	0.058x

Annual Cash Flow Conversion Efficiency for Ilex Medical (2008–2025)

The table below shows the annual cash flow conversion efficiency of Ilex Medical from 2008 to 2025. Review Ilex Medical free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	ILA684.71 Million ≈ $1.84 Million	ILA72.87 Million ≈ $195.36K	0.106x	-15.72%
2024-12-31	ILA646.49 Million ≈ $1.73 Million	ILA81.63 Million ≈ $218.85K	0.126x	-2.12%
2023-12-31	ILA623.51 Million ≈ $1.67 Million	ILA80.43 Million ≈ $215.64K	0.129x	+13.41%
2022-12-31	ILA613.10 Million ≈ $1.64 Million	ILA69.74 Million ≈ $186.97K	0.114x	-75.81%
2021-12-31	ILA575.57 Million ≈ $1.54 Million	ILA270.68 Million ≈ $725.67K	0.470x	+14.35%
2020-12-31	ILA443.54 Million ≈ $1.19 Million	ILA182.40 Million ≈ $489.02K	0.411x	+56.71%
2019-12-31	ILA323.48 Million ≈ $867.23K	ILA84.89 Million ≈ $227.58K	0.262x	+31.43%
2018-12-31	ILA293.49 Million ≈ $786.83K	ILA58.60 Million ≈ $157.11K	0.200x	-30.04%
2017-12-31	ILA266.15 Million ≈ $713.53K	ILA75.96 Million ≈ $203.65K	0.285x	+446.57%
2016-12-31	ILA244.51 Million ≈ $655.52K	ILA12.77 Million ≈ $34.23K	0.052x	-73.88%
2015-12-31	ILA225.99 Million ≈ $605.87K	ILA45.17 Million ≈ $121.11K	0.200x	-48.76%
2014-12-31	ILA204.60 Million ≈ $548.53K	ILA79.81 Million ≈ $213.98K	0.390x	+275.55%
2013-12-31	ILA214.38 Million ≈ $574.74K	ILA22.27 Million ≈ $59.70K	0.104x	-50.83%
2012-12-31	ILA259.96 Million ≈ $696.93K	ILA54.92 Million ≈ $147.23K	0.211x	+17.88%
2011-12-31	ILA282.99 Million ≈ $758.68K	ILA50.71 Million ≈ $135.96K	0.179x	-44.23%
2010-12-31	ILA120.80 Million ≈ $323.87K	ILA38.82 Million ≈ $104.08K	0.321x	-17.86%
2009-12-31	ILA127.32 Million ≈ $341.33K	ILA49.81 Million ≈ $133.54K	0.391x	+47.29%
2008-12-31	ILA109.44 Million ≈ $293.42K	ILA29.07 Million ≈ $77.94K	0.266x	--

About Ilex Medical

TA:ILX Israel Medical Distribution

Market Cap

$140.14 Million

ILA52.27 Billion ILA

Market Cap Rank

#17724 Global

#223 in Israel

Share Price

ILA4672.00

Change (1 day)

+4.36%

52-Week Range

ILA4303.00 - ILA7080.00

All Time High

ILA15645.73